← FDA Drug Approvals (Drugs@FDA)

ALISKIREN HEMIFUMARATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PH HEALTH · Approved 2019-03-22

Drug application

FDA Application #
ANDA206665
Application type
Abbreviated New Drug Application (Generic)
Brand name
ALISKIREN HEMIFUMARATE
Generic name
ALISKIREN
Active ingredients
ALISKIREN HEMIFUMARATE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
PH HEALTH
Manufacturer
Endo USA, Inc.
First approval
2019-03-22

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown